The first Indian-made cervical cancer vaccine, “CERVAVAC,” has launched by Home Minister Amit Shah, Adar Poonawalla, and the Director of Government & Regulatory Affairs at Serum Institute of India, Prakash K Singh.
Adar Poonawala, the Chief Executive Officer of Serum Institute of India (SII), has tweeted that on National Girl Child Day and cervical cancer awareness month, Serum Institute of India is launching its made-in-India HPV vaccine product.
The newly launched vaccine is a Human Papillomavirus vaccine to prevent the risk and occurrence of cervical cancer. This quadrivalent vaccine is developed under the partnership of BIRAC with the Bill and Melinda Gates Foundation and DBT, held by Serum Institute of India Pvt. Ltd.
Previously, Dr. NK Arora announced that the vaccine would most likely be available in our Indian markets by the end of April. Now that the vaccine has already got the regulators’ clearance, it will most likely be available in the markets before May 2023.